Menu

Laura MITROFAN

LILLE

En résumé

My previous professional experiences can be resumed at two types of missions: on the bench side and on the strategic marketing side.

On bench side, I have experience in preclinical PK and PD studies both in vitro and in vivo applied in oncology research. I applied and improved techniques ranging from cellular and molecular biology to biochemical techniques.

On the business and strategic marketing side, I was in charge (in close interaction with my clients) with analysis of different qualitative and quantitative aspects like: technology positioning (3D cell based assay, microfluidic) according to the industrial demands; strategy proposal for R&D and business development in line with regulatory constraints specific for different therapeutic (oncology, neuroscience, diabetes, (stem) cell therapy etc) and geographical areas; precise evaluation of the global burden of the diagnosis on health system; market forecasting of the diagnosis tool for 5 years for four cancer types (breast, colorectal, prostate and lung); annual and total volume market evaluations (and forecasting) using epidemiological and field analysis etc.

Entreprises

  • MTI - MTI Consultant

    2012 - maintenant LYSTANCE (Start-up In vitro Oncology Diagnostic - solid cancers)
    - Business plan
    - Market (volume and value) analysis
    - Financial and strategy analysis for market entry in France and SUA
    - Legal frame for market entry (FDA, CLIA, AMM)

    REUNICA-IMRI (Management de la Recherche et de l'Innovation)
    - Prospective of medico-economic variables in telemedicine of chronic heart failure

  • UMR908 - Senior scientist

    2010 - 2012 Key accomplishments:
    · Conceive, plan, and conduct independent project in
    breast cancer research;
    · Identify the organizations which might finance my
    project and write grants;
    · Define the feasibility of the strategy from technical
    and financial point of view;
    · Bring innovative ideas in order to be the first in the
    scientific community who publish it.
  • LPRO - A UMR INSERM 957 Nantes - Research engineer

    2009 - 2010 Key accomplishments:
    · Set up an original technique which allows purifying
    the infiltrating macrophages in osteosarcomas in vivo.
  • Kuopio University, Department of Pharmaceutics (Research financed by Novartis AG, Basle, Switzerland - Post-doc researcher

    2007 - 2009 Key accomplishments:
    ·Write grants assessment, articles and reports on
    ongoing experimental process for Novartis and my
    department;
    · Set up fruitful international collaboration with
    different teams from Nantes and Aberdeen;
  • MacoProduction, Tourcoing, France - PhD Researcher

    2002 - 2006 Key accomplishments:
    · Scientific reports and research in order to validate by
    French Health Products Safety Agency (AFSSAPS)
    of the ABC® – Automate Blood Collector designed
    by MacoPharma, which allow to collect whole blood
    on a constant haematocrit.

Formations

  • Université Paris Dauphine - INSTN - ENS Cachan - Mines ParisTech (Paris)

    Paris 2012 - 2013 Management of Innovation and Technology - financial analysis, intellectual propriety, international marketing strategy, technological survey; Design Thinking using a practical approach of Concept-Knowledge Theory from Ecole Mines ParisTech etc
  • Université Lille 1 Sciences Et Technologies

    Villeneuve D'Ascq 2002 - 2006 PhD CIFRE

Réseau

Annuaire des membres :